Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma

NCT05193006 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05193006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05193006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Unknown status
Start date
December 28, 2021
Completion date
January 1, 2023
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal malignant mesothelioma